These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 21424860)

  • 1. How do mutations in contractile proteins cause the primary familial cardiomyopathies?
    Marston SB
    J Cardiovasc Transl Res; 2011 Jun; 4(3):245-55. PubMed ID: 21424860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
    Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
    Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.
    Purevjav E; Arimura T; Augustin S; Huby AC; Takagi K; Nunoda S; Kearney DL; Taylor MD; Terasaki F; Bos JM; Ommen SR; Shibata H; Takahashi M; Itoh-Satoh M; McKenna WJ; Murphy RT; Labeit S; Yamanaka Y; Machida N; Park JE; Alexander PM; Weintraub RG; Kitaura Y; Ackerman MJ; Kimura A; Towbin JA
    Hum Mol Genet; 2012 May; 21(9):2039-53. PubMed ID: 22286171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical and energetic consequences of HCM-causing mutations.
    Ferrantini C; Belus A; Piroddi N; Scellini B; Tesi C; Poggesi C
    J Cardiovasc Transl Res; 2009 Dec; 2(4):441-51. PubMed ID: 20560002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-tropomyosin mutations in inherited cardiomyopathies.
    Redwood C; Robinson P
    J Muscle Res Cell Motil; 2013 Aug; 34(3-4):285-94. PubMed ID: 24005378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
    Nanni L; Pieroni M; Chimenti C; Simionati B; Zimbello R; Maseri A; Frustaci A; Lanfranchi G
    Biochem Biophys Res Commun; 2003 Sep; 309(2):391-8. PubMed ID: 12951062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dilated cardiomyopathy mutation blunts adrenergic response and induces contractile dysfunction under chronic angiotensin II stress.
    Wilkinson R; Song W; Smoktunowicz N; Marston S
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1936-46. PubMed ID: 26432839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere shortening is a hallmark of genetic cardiomyopathies.
    Chang ACY; Chang ACH; Kirillova A; Sasagawa K; Su W; Weber G; Lin J; Termglinchan V; Karakikes I; Seeger T; Dainis AM; Hinson JT; Seidman J; Seidman CE; Day JW; Ashley E; Wu JC; Blau HM
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9276-9281. PubMed ID: 30150400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
    Mirza M; Marston S; Willott R; Ashley C; Mogensen J; McKenna W; Robinson P; Redwood C; Watkins H
    J Biol Chem; 2005 Aug; 280(31):28498-506. PubMed ID: 15923195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?
    Dweck D; Hus N; Potter JD
    J Biol Chem; 2008 Nov; 283(48):33119-28. PubMed ID: 18820258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
    Lakdawala NK; Thune JJ; Colan SD; Cirino AL; Farrohi F; Rivero J; McDonough B; Sparks E; Orav EJ; Seidman JG; Seidman CE; Ho CY
    Circ Cardiovasc Genet; 2012 Oct; 5(5):503-10. PubMed ID: 22949430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies.
    Yotti R; Seidman CE; Seidman JG
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():129-153. PubMed ID: 30978303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac and skeletal myopathies: can genotype explain phenotype?
    Marston SB; Hodgkinson JL
    J Muscle Res Cell Motil; 2001; 22(1):1-4. PubMed ID: 11563546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
    Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
    Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium regulation by troponin and its genetic disorder in striated muscle contraction].
    Ohtsuki I
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):20P-23P. PubMed ID: 12491770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilated cardiomyopathy: the complexity of a diverse genetic architecture.
    Hershberger RE; Hedges DJ; Morales A
    Nat Rev Cardiol; 2013 Sep; 10(9):531-47. PubMed ID: 23900355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited cardiomyopathies as a troponin disease.
    Harada K; Morimoto S
    Jpn J Physiol; 2004 Aug; 54(4):307-18. PubMed ID: 15631686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.
    van Dijk SJ; Dooijes D; dos Remedios C; Michels M; Lamers JM; Winegrad S; Schlossarek S; Carrier L; ten Cate FJ; Stienen GJ; van der Velden J
    Circulation; 2009 Mar; 119(11):1473-83. PubMed ID: 19273718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.